OURVITA
LIVE

Serial Number

79446104

Owner

FARMACEUTICI PROCEMSA S.P.A.

Attorney

MATTHEW FRISBEE

Filing Date

Dec 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

OURVITA Trademark

Serial Number: 79446104

OURVITA is a trademark filed by FARMACEUTICI PROCEMSA S.P.A. on December 23, 2025. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 32 (Light Beverages). The application is currently pending registration.

Owner Contact Info

FARMACEUTICI PROCEMSA S.P.A. (3 trademarks)

VIA MENTANA, 10
NICHELINO (TURIN) I-10042 , IT

Entity Type: 99

Trademark Details

Filing Date

December 23, 2025

Registration Date

Not Registered

Published for Opposition

October 27, 2026

Goods & Services

medicated creams for treating dermatological conditions; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical use; dietary supplements and dietetic preparations adapted for medical purposes for human beings; vitamin supplement patches; dietary supplemental drinks; animal feed supplements; dietary supplements for human beings; nutritional supplements; food supplements for non-medical purposes; powdered nutritional supplement energy drink mix; mouthwashes for medical purposes; antibacterial gel cleaners; pharmaceutical body gel preparations for dermatological use; gelatine capsules, empty, for pharmaceuticals; capsules sold empty for medicines; capsules sold empty for pharmaceutical purposes; capsules sold empty for pharmaceuticals

Technical consultancy in relation to research services relating to foods and dietary supplements; research and development in the pharmaceutical and biotechnology fields; consultancy relating to pharmaceutical research and development; cosmetic research.

Proteins for use in the manufacture of food supplements; vitamins for use in the manufacture of food supplements; antioxidants for use in the manufacture of food supplements; chemical supplements for use in the manufacture of vitamins; protein for use in the manufacture of cosmetics; vitamins for use in the manufacture of cosmetics; chemical preparations for use in the manufacture of cosmetics; chemical compositions and biological preparations for use in the manufacture of cosmetics

Non-medicated cosmetics; non-medicated toiletry preparations; cosmetics; skin cream; non-medicated soaps; non-medicated soaps in gel form; perfume oils for the manufacture of cosmetic preparations; cleaning preparation; bleaching preparations for laundry use; substances for laundry use, namely, fabric softeners, laundry detergents, and laundry starch

Non-alcoholic beverages, namely, isotonic beverages; mineral and aerated waters; fruit beverages and fruit juices; syrups used in the preparation of soft drinks; other non-alcoholic preparations for making beverages, namely, powders for making soft drinks; energy drinks; soft drinks for energy supply; concentrates for use in the preparation of energy drinks

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 7, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 7, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 24, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 24, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Sep 24, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Sep 24, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 24, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2026 TROA
REFUSAL PROCESSED BY IB
Jul 9, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 21, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jun 21, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 1, 2026 RFCR
NON-FINAL ACTION WRITTEN
Apr 30, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 24, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 20, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 19, 2026 REPR